Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase
Year: 2000
Type: article
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: alendronate, farnesyl diphosphate synthase, bisphosphonates, mevalonate pathway, protein prenylation, isoprenoid biosynthesis, geranylgeranyl diphosphate, isopentenyl diphosphate isomerase, pamidronate, risedronate, etidronate, clodronate, osteoclasts, sterol biosynthesis, enzyme inhibition, osteoporosis treatment
Open Access status: closed
OpenAlex ID: W2076107807
